Comparison of the ocular hypotensive effects of bimatoprost and timolol-dorzolamide combination in patients with elevated intraocular pressure: a 6-month study.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Acta ophthalmologica

• Publication date

  2006-09-18

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/J.1600-0420.2006.00754.XPMID 17244215
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Safety and Efficacy of Bimatoprost 0.03% versus Timolol Maleate 0.5%/Dorzolamide 2% Fixed Combination

  2005cited by this paper
• Efficacy and tolerability of the dorzolamide 2%/timolol 0.5% combination (COSOPT) versus 0.005% (XALATAN) in the treatment of ocular hypertension or glaucoma: results from two randomized clinical trials.

  2004cited by this paper
• Update on the mechanism of action of bimatoprost: a review and discussion of new evidence.

  2004cited by this paper
• A randomised, double masked, multicentre clinical trial comparing bimatoprost and timolol for the treatment of glaucoma and ocular hypertension

  2003cited by this paper
• A 3-month randomized controlled trial of bimatoprost (LUMIGAN) versus combined timolol and dorzolamide (Cosopt) in patients with glaucoma or ocular hypertension.

  2003cited by this paper
• Bimatoprost and travoprost: a review of recent studies of two new glaucoma drugs.

  2002cited by this paper
• Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial.

  2002cited by this paper
• Effects of AGN 192024, a new ocular hypotensive agent, on aqueous dynamics.

  2001cited by this paper
• The advanced glaucoma intervention study (AGIS): 7. the relationship between control of intraocular pressure and visual field deterioration

  2000cited by this paper
• Brimonidine 0.2% versus dorzolamide 2% each given three times daily to reduce intraocular pressure.

  2000cited by this paper
• The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators.

  2000cited by this paper
• Comparison of the safety and efficacy of the fixed combination of dorzolamide/timolol and the concomitant administration of dorzolamide and timolol: a clinical equivalence study

  1998cited by this paper
• A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide. Dorzolamide-Timolol Study Group.

  1998cited by this paper
• The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components. Dorzolamide-Timolol Study Group.

  1998cited by this paper
• A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide.

  1998cited by this paper
• Dorzolamide hydrochloride: A topically active, carbonic anhydrase inhibitor for the treatment of glaucoma

  1997cited by this paper
• The use of dorzolamide and pilocarpine as adjunctive therapy to timolol in patients with elevated intraocular pressure. The Dorzolamide Additivity Study Group.

  1996cited by this paper
• Effects of PhXA41, A New Prostaglandin F2α Analog, on Aqueous Humor Dynamics in Human Eyes

  1993cited by this paper
• Effects of PhXA41, a new prostaglandin F2 alpha analog, on aqueous humor dynamics in human eyes.

  1993cited by this paper
• MK-507 versus sezolamide. Comparative efficacy of two topically active carbonic anhydrase inhibitors.

  1991cited by this paper
• Laboratory and clinical studies on the mechanism of action of timolol.

  1983cited by this paper

• Evaluation of the Effectiveness of Using a Fixed Combination of Dorzolamide 2.0 % and Timolol 0.5 % in Primary Open-­Angle Glaucoma

  2024cites this paper
• Therapeutic Class Overview Ophthalmic Agents , Intraocular Pressure ( IOP )-Modifying

  2020cites this paper
• OCT angiography in a comprehensive assessment of hypotensive therapy effectiveness in patients with primary open-angle glaucoma

  2019cites this paper
• To study the comparison of efficacy and side effect profile of bimatoprost 0.03% versus fixed combination timolol 0.5% and dorzolamide 2% in patients with primary open angle glaucoma or ocular hypertension

  2016cites this paper
• Therapeutic Class Overview Attention Deficit/Hyperactivity Disorder (ADHD) Agents and Stimulants

  2014cites this paper
• [Life expectancy of patients with primary glaucoma, residents of a large industrial city of Siberia].

  2014cites this paper
• • Overview/Summary: Treatment of glaucoma currently focuses on decreasing IOP by one of three methods: laser therapy, surgery, or medical intervention.

  2013cites this paper
• Long-term Medical Management of Primary Open-Angle Glaucoma and Ocular Hypertension in the UK: Optimizing Cost-Effectiveness and Clinic Resources by Minimizing Therapy Switches

  2012cites this paper
• Intraocular Pressure-Lowering Effects of Commonly Used Fixed-Combination Drugs with Timolol: A Systematic Review and Meta-Analysis

  2012cites this paper
• Mixed treatment comparison and meta-regression of the efficacy and safety of prostaglandin analogues and comparators for primary open-angle glaucoma and ocular hypertension

  2010cites this paper
• Effectiveness of Dorzolamide–Timolol (COSOPT) in Patients Who Were Treatment Naive for Open-Angle Glaucoma or Ocular Hypertension: The COSOPT First-Line Study

  2010cites this paper
• Efficacy, safety and tolerability of combination therapy with timolol and dorzolamide in glaucoma and ocular hypertension

  2010cites this paper
• Efficacy, safety and tolerability of combination therapy with timolol and dorzolamide in glaucoma and ocular hypertension

  2010cites this paper
• Comparison of the effects of dorzolamide/timolol and latanoprost/timolol fixed combinations upon intraocular pressure and progression of visual field damage in primary open-angle glaucoma

  2010cites this paper
• Predictors for visual field progression and the effects of treatment with dorzolamide 2% or brinzolamide 1% each added to timolol 0.5% in primary open‐angle glaucoma

  2009cites this paper
• Bimatoprost

  2009cites this paper
• Recent advances in pharmacotherapy of glaucoma

  2008cites this paper
• Rational use of the fixed combination of dorzolamide – timolol in the management of raised intraocular pressure and glaucoma

  2008influential citation
• Therapeutic Class Overview Ophthalmic Prostaglandin Analogs

  year unknowncites this paper